Commercialising cardiac autonomic modulation to treat Atrial Fibrillation

Project description

Novel treatment targets the origin of atrial fibrillation

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

ATRIAN MEDICAL LIMITED

Address

Unit 204 Nuig Business Innovation Centre Upper Newcastle
H91W60E Galway
Ireland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 348 941